Giselle Sholler: Polyamine Inhibition with DFMO
Giselle Sholler, Division Chief Pediatric Hematology/Oncology/BMT at Penn State Health Children’s Hospital, posted on LinkedIn about recent paper by Joseph Schramm et al., titled “Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy” published on MDPI.
Authors: Joseph Schramm, Chloe Sholler, Leah Menachery, Laura Vazquez, and Giselle Saulnier Sholler
“Grateful to Dr. Rupert Handgretinger for inviting us to contribute our review of DFMO in the Special Issue of High-Risk Neuroblastoma: New Clinical Insights and Challenges! Proud of my team and co-authors – Dr. Joe Schramm, Chloe Sholler, Leah Menachery and Laura Vazquez for our newest publication – Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023